Expanded Access Program (EAP) in Bahrain

About Expanded Access Program (EAP)

Structured programs offering access to investigational drugs outside of clinical trials.

How Expanded Access Program (EAP) works in Bahrain

Bahrain's NHRA accepts named-patient import requests for rare-disease and specialty drugs not registered locally.

Patients in Bahrain seeking access under Expanded Access Program (EAP) typically follow this flow: a licensed physician in Bahrain issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.

Documents required in Bahrain

• Physician prescription and clinical-justification letter.
• Patient identification and consent.
• Country-specific NPP/personal-import form.
• Hospital or clinic attestation where required.

Typical timeline

End-to-end 2-6 weeks in most tier 2 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.

Start a request

Start a request under Expanded Access Program (EAP) in Bahrain